MENU
+Compare
AXGN
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$24.05
Change
-$0.04 (-0.17%)
Capitalization
1.11B

AXGN Axogen Forecast, Technical & Fundamental Analysis

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair... Show more

AXGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for AXGN with price predictions
Nov 12, 2025

Aroon Indicator for AXGN shows an upward move is likely

AXGN's Aroon Indicator triggered a bullish signal on November 12, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 224 similar instances where the Aroon Indicator showed a similar pattern. In of the 224 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 21, 2025. You may want to consider a long position or call options on AXGN as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AXGN just turned positive on October 22, 2025. Looking at past instances where AXGN's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

AXGN moved above its 50-day moving average on October 16, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AXGN advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

AXGN broke above its upper Bollinger Band on October 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.200) is normal, around the industry mean (63.534). P/E Ratio (0.000) is within average values for comparable stocks, (37.086). AXGN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.687). AXGN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (5.160) is also within normal values, averaging (79.919).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AXGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

AXGN is expected to report earnings to fall 25.58% to 8 cents per share on March 03

Axogen AXGN Stock Earnings Reports
Q4'25
Est.
$0.09
Q3'25
Beat
by $0.05
Q2'25
Beat
by $0.06
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.04
The last earnings report on October 29 showed earnings per share of 11 cents, beating the estimate of 7 cents. With 168.38K shares outstanding, the current market capitalization sits at 1.11B.
A.I.Advisor
published Dividends

AXGN paid dividends on February 12, 2010

Axogen AXGN Stock Dividends
А quarterly dividend of $1.00 per share was paid with a record date of February 12, 2010, and an ex-dividend date of January 27, 2010. Read more...
A.I. Advisor
published General Information

General Information

a provider of products and technologies for peripheral nerve reconstruction and regeneration

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
13631 Progress Boulevard
Phone
+1 386 462-6800
Employees
428
Web
https://www.axogeninc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MOWIX22.130.22
+1.00%
Moerus Worldwide Value Institutional
NPNRX52.310.21
+0.40%
Neuberger Berman Large Cap Value R3
BIERX28.360.06
+0.21%
Brandes International Equity R6
SAMKX41.650.03
+0.07%
SA US Core Market
LIGCX11.44-0.03
-0.26%
Loomis Sayles International Growth C

AXGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AXGN has been loosely correlated with TCMD. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AXGN jumps, then TCMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXGN
1D Price
Change %
AXGN100%
-1.51%
TCMD - AXGN
43%
Loosely correlated
-2.03%
TMDX - AXGN
38%
Loosely correlated
-2.42%
XRAY - AXGN
36%
Loosely correlated
-1.28%
ITGR - AXGN
31%
Poorly correlated
-0.44%
CLPT - AXGN
31%
Poorly correlated
-3.97%
More

Groups containing AXGN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXGN
1D Price
Change %
AXGN100%
-1.51%
Medical/Nursing Services
industry (215 stocks)
25%
Poorly correlated
-2.32%
Health Services
industry (422 stocks)
4%
Poorly correlated
-2.10%